The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyazaki, Y.
Right arrow Articles by Yoshida, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyazaki, Y.
Right arrow Articles by Yoshida, H.
The Journal of Immunology, 2005, 175: 2401-2407.
Copyright © 2005 by The American Association of Immunologists

Exacerbation of Experimental Allergic Asthma by Augmented Th2 Responses in WSX-1-Deficient Mice1

Yoshiyuki Miyazaki*,{dagger},{ddagger}, Hiromasa Inoue§, Mikiko Matsumura§, Koichiro Matsumoto§, Takako Nakano§, Miyuki Tsuda§, Shinjiro Hamano, Akihiko Yoshimura{dagger} and Hiroki Yoshida2,*,{dagger},{ddagger}

* PRESTO, Japan Science and Technology Agency, Saitama, Japan; {dagger} Division of Molecular and Cellular Immunology, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan; {ddagger} Department of Biomolecular Sciences, Faculty of Medicine, Saga University, Saga, Japan; and § Research Institute for Diseases of the Chest and Department of Parasitology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan

WSX-1 (IL-27R) is a class I cytokine receptor with homology to gp130 and IL-12 receptors and is typically expressed on CD4+ T lymphocytes. Although previous reports have clarified that IL-27/WSX-1 signaling plays critical roles in both Th1 differentiation and attenuation of cell activation and proinflammatory cytokine production during some bacterial or protozoan infections, little is known about the importance of WSX-1 in cytokine-mediated diseases of allergic origin. To this aim, we took advantage of WSX-1-deficient (WSX-1–/–) mice and induced experimental asthma, in which Th2 cytokines are central modulators of the pathology. OVA-challenged WSX-1–/– mice showed marked enhancement of airway responsiveness with goblet cell hyperplasia, pulmonary eosinophil infiltration, and increased serum IgE levels compared with wild-type mice. Production of Th2 cytokines, which are largely responsible for the pathogenesis of asthma, was augmented in the lung or in the culture supernatants of peribronchial lymph node CD4+ T cells from WSX-1–/– mice compared with those from wild-type mice. Surprisingly, IFN-{gamma} production was also enhanced in WSX-1–/– mice, albeit at a low concentration. The cytokine overproduction, thus, seems independent from the Th1-promoting property of WSX-1. These results demonstrated that IL-27/WSX-1 also plays an important role in the down-regulation of airway hyper-reactivity and lung inflammation during the development of allergic asthma through its suppressive effect on cytokine production.




This article has been cited by other articles:


Home page
J. Immunol.Home page
H. Fujita, A. Teng, R. Nozawa, Y. Takamoto-Matsui, H. Katagiri-Matsumura, Z. Ikezawa, and Y. Ishii
Production of Both IL-27 and IFN-{gamma} after the Treatment with a Ligand for Invariant NK T Cells Is Responsible for the Suppression of Th2 Response and Allergic Inflammation in a Mouse Experimental Asthma Model
J. Immunol., July 1, 2009; 183(1): 254 - 260.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
S. Kempe, P. Heinz, E. Kokai, O. Devergne, N. Marx, and T. Wirth
Epstein-Barr Virus-Induced Gene-3 Is Expressed in Human Atheroma Plaques
Am. J. Pathol., July 1, 2009; 175(1): 440 - 447.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. G. Perrigoue, C. Zaph, K. Guild, Y. Du, and D. Artis
IL-31-IL-31R Interactions Limit the Magnitude of Th2 Cytokine-Dependent Immunity and Inflammation following Intestinal Helminth Infection
J. Immunol., May 15, 2009; 182(10): 6088 - 6094.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. Matsui, T. Kishida, H. Nakano, K. Yoshimoto, M. Shin-Ya, T. Shimada, S. Nakai, J. Imanishi, T. Yoshimoto, Y. Hisa, et al.
Interleukin-27 Activates Natural Killer Cells and Suppresses NK-Resistant Head and Neck Squamous Cell Carcinoma through Inducing Antibody-Dependent Cellular Cytotoxicity
Cancer Res., March 15, 2009; 69(6): 2523 - 2530.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
N Sugiyama, H Nakashima, T Yoshimura, A Sadanaga, S Shimizu, K Masutani, T Igawa, M Akahoshi, K Miyake, A Takeda, et al.
Amelioration of human lupus-like phenotypes in MRL/lpr mice by overexpression of interleukin 27 receptor {alpha} (WSX-1)
Ann Rheum Dis, October 1, 2008; 67(10): 1461 - 1467.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
A. V. Villarino, D. Artis, J. S. Bezbradica, O. Miller, C. J. M. Saris, S. Joyce, and C. A. Hunter
IL-27R deficiency delays the onset of colitis and protects from helminth-induced pathology in a model of chronic IBD
Int. Immunol., June 1, 2008; 20(6): 739 - 752.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Wang, Y. Miyazaki, Y. Shinozaki, and H. Yoshida
Augmentation of Antigen-Presenting and Th1-Promoting Functions of Dendritic Cells by WSX-1(IL-27R) Deficiency
J. Immunol., November 15, 2007; 179(10): 6421 - 6428.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Yoshimoto, T. Yoshimoto, K. Yasuda, J. Mizuguchi, and K. Nakanishi
IL-27 Suppresses Th2 Cell Development and Th2 Cytokines Production from Polarized Th2 Cells: A Novel Therapeutic Way for Th2-Mediated Allergic Inflammation
J. Immunol., October 1, 2007; 179(7): 4415 - 4423.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. C. Fitzgerald, B. Ciric, T. Touil, H. Harle, J. Grammatikopolou, J. D. Sarma, B. Gran, G.-X. Zhang, and A. Rostami
Suppressive Effect of IL-27 on Encephalitogenic Th17 Cells and the Effector Phase of Experimental Autoimmune Encephalomyelitis
J. Immunol., September 1, 2007; 179(5): 3268 - 3275.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Molle, M. Nguyen, V. Flamand, J. Renneson, F. Trottein, D. De Wit, F. Willems, M. Goldman, and S. Goriely
IL-27 Synthesis Induced by TLR Ligation Critically Depends on IFN Regulatory Factor 3
J. Immunol., June 15, 2007; 178(12): 7607 - 7615.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. G. Shainheit, R. Saraceno, L. E. Bazzone, L. I. Rutitzky, and M. J. Stadecker
Disruption of Interleukin-27 Signaling Results in Impaired Gamma Interferon Production but Does Not Significantly Affect Immunopathology in Murine Schistosome Infection
Infect. Immun., June 1, 2007; 75(6): 3169 - 3177.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. G. Perrigoue, J. Li, C. Zaph, M. Goldschmidt, P. Scott, F. J. de Sauvage, E. J. Pearce, N. Ghilardi, and D. Artis
IL-31-IL-31R interactions negatively regulate type 2 inflammation in the lung
J. Exp. Med., March 19, 2007; 204(3): 481 - 487.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
J. Liu, X. Guan, and X. Ma
Regulation of IL-27 p28 gene expression in macrophages through MyD88- and interferon-{gamma}-mediated pathways
J. Exp. Med., January 22, 2007; 204(1): 141 - 152.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. C. El Kasmi, J. Holst, M. Coffre, L. Mielke, A. de Pauw, N. Lhocine, A. M. Smith, R. Rutschman, D. Kaushal, Y. Shen, et al.
General Nature of the STAT3-Activated Anti-Inflammatory Response
J. Immunol., December 1, 2006; 177(11): 7880 - 7888.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.